ERBB2 and neoplasm: showed that miR-193a-5p supplementation in KYSE70 cells, subcutaneously injected into immunodeficient mice, inhibited tumor growth by reducing Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2)expression in vivo (48).